AIM: Skeletal muscle interleukin-6 (IL-6) expression is induced by continuous contraction, overload-induced hypertrophy and during muscle regeneration. The loss of IL-6 can alter skeletal muscle's growth and extracellular matrix remodelling response to overload-induced hypertrophy. Insulin-like growth factor-1 (IGF-1) gene expression and related signalling through Akt/mTOR is a critical regulator of muscle mass. The significance of IL-6 expression during the recovery from muscle atrophy is unclear. This study's purpose was to determine the effect of IL-6 loss on mouse gastrocnemius (GAS) muscle mass during recovery from hindlimb suspension (HS)-induced atrophy. METHODS: Female C57BL/6 [wild type (WT)] and IL-6 knockout (IL-6 KO) mice at 10 weeks of age were assigned to control, HS or HS followed by normal cage ambulation groups. RESULTS: GAS muscle atrophy was induced by 10 days of HS. HS induced a 20% loss of GAS mass in both WT and IL-6 KO mice. HS+7 days of recovery restored WT GAS mass to cage-control values. GAS mass from IL-6 KO mice did not return to cage-control values until HS+14 days of recovery. Both IGF-1 mRNA expression and Akt/mTOR signalling were increased in WT muscle after 1 day of recovery. In IL-6 KO muscle, IGF-1 mRNA expression was decreased and Akt/mTOR signalling was not induced after 1 day of recovery. MyoD and myogenin mRNA expression were both induced in WT muscle after 1 day of recovery, but not in IL-6 KO muscle. CONCLUSION: Muscle IL-6 expression appears important for the initial growth response during the recovery from disuse.
AIM: Skeletal muscle interleukin-6 (IL-6) expression is induced by continuous contraction, overload-induced hypertrophy and during muscle regeneration. The loss of IL-6 can alter skeletal muscle's growth and extracellular matrix remodelling response to overload-induced hypertrophy. Insulin-like growth factor-1 (IGF-1) gene expression and related signalling through Akt/mTOR is a critical regulator of muscle mass. The significance of IL-6 expression during the recovery from muscle atrophy is unclear. This study's purpose was to determine the effect of IL-6 loss on mouse gastrocnemius (GAS) muscle mass during recovery from hindlimb suspension (HS)-induced atrophy. METHODS: Female C57BL/6 [wild type (WT)] and IL-6 knockout (IL-6 KO) mice at 10 weeks of age were assigned to control, HS or HS followed by normal cage ambulation groups. RESULTS: GAS muscle atrophy was induced by 10 days of HS. HS induced a 20% loss of GAS mass in both WT and IL-6 KO mice. HS+7 days of recovery restored WT GAS mass to cage-control values. GAS mass from IL-6 KO mice did not return to cage-control values until HS+14 days of recovery. Both IGF-1 mRNA expression and Akt/mTOR signalling were increased in WT muscle after 1 day of recovery. In IL-6 KO muscle, IGF-1 mRNA expression was decreased and Akt/mTOR signalling was not induced after 1 day of recovery. MyoD and myogenin mRNA expression were both induced in WT muscle after 1 day of recovery, but not in IL-6 KO muscle. CONCLUSION: Muscle IL-6 expression appears important for the initial growth response during the recovery from disuse.
Authors: Richard W E Clarkson; Marion P Boland; Ekaterini A Kritikou; Jennifer M Lee; Tom C Freeman; Paul G Tiffen; Christine J Watson Journal: Mol Endocrinol Date: 2005-11-17
Authors: Joseph M McClung; Kristen A Mehl; Raymond W Thompson; Larry L Lowe; James A Carson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2005-06 Impact factor: 3.619
Authors: Jos L J van der Velden; Ramon C J Langen; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger; Annemie M W J Schols Journal: Am J Physiol Cell Physiol Date: 2005-09-14 Impact factor: 4.249
Authors: John T Kim; Benjamin M Kasukonis; Lemuel A Brown; Tyrone A Washington; Jeffrey C Wolchok Journal: Exp Gerontol Date: 2016-07-17 Impact factor: 4.032
Authors: Richard A Perry; Lemuel A Brown; David E Lee; Jacob L Brown; Jamie I Baum; Nicholas P Greene; Tyrone A Washington Journal: Mech Ageing Dev Date: 2016-06-18 Impact factor: 5.432
Authors: Jena R White; Amy L Confides; Stephanie Moore-Reed; Johanna M Hoch; Esther E Dupont-Versteegden Journal: Exp Gerontol Date: 2015-02-12 Impact factor: 4.032